Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets EP News Bureau Oct 29, 2020 Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets EP News Bureau Sep 9, 2020 They are oral diabetes medicines that help control blood sugar levels
Alembic Pharma gets tentative nod from USFDA for Empagliflozin and Linagliptin tablets EP News Bureau Aug 27, 2020 Empagliflozin and Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
